跳至主要内容
临床试验/JPRN-UMIN000024178
JPRN-UMIN000024178招募中未知

Efficacy and safety of combination therapy of tocilizumab and abatacept in patients with refractory systemic-onset juvenile idiopathic arthritis - Efficacy and safety of combination therapy of tocilizumab and abatacept in patients with refractory systemic-onset juvenile idiopathic arthritis

Yokohama City University Hospital Department of Pediatrics0 个研究点目标入组 5 人开始时间: 2016年9月28日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Pulmonary tuberculosis, active bacterial infection or deep mycotic infection 2 Infection of HIV, HCV, HBV 3 Administration of live vaccine within 4 weeks 4 Cardiac dysfunction 5 Pregnant subjects or subjects who do not agree with contraception during the study period

研究者

发起方
Yokohama City University Hospital Department of Pediatrics

相似试验

Efficacy and safety of combination therapy of... | 临床试验